Intra-Cellular Therapies announced the promotion of Michael Halstead, J.D. to the position of President. Halstead is currently serving as Executive Vice President and General Counsel. In this newly created leadership role, Halstead will oversee several functions within the Company including legal, human resources, manufacturing & supply chain, quality, compliance, information technology, and external innovation. He will continue to report to Dr. Sharon Mates, Chairman and Chief Executive Officer. Intra-Cellular Therapies also announced that Senior Vice President and Chief Financial Officer, CFO, Larry Hineline, will be retiring after more than 20 years of service.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ITCI:
- Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
- Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
- Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
- JPMorgan biotech analysts to hold an analyst/industry conference call
- Intra-Cellular price target raised to $82 from $72 at Needham
